[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336693-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-336693-en":122},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","liquid-biopsy-paving-a-new-avenue-for-cancer-research","Liquid biopsy: paving a new avenue for cancer research","","Cancer diagnosis and molecular profiling still depend heavily on invasive tissue biopsies or clinical imaging, creating constraints that limit access, safety, and the ability to capture tumor heterogeneity over time. Liquid biopsy addresses these limitations by analyzing components such as circulating tumor cells, circulating free or tumor DNA, circulating cell-free RNA, extracellular vesicles, and tumor-educated platelets from body fluids. Molecular characterization enables biomarker discovery for early detection, prognosis, therapy assessment, and post-treatment monitoring. This review surveys processing technologies, methodologies, and key clinical applications, highlighting how these biosources mirror primary tumor biology and interactions.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/liquid-biopsy-paving-a-new-avenue-for-cancer-research/336693/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/liquid-biopsy-paving-a-new-avenue-for-cancer-research/336693.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"What does the review cover regarding technologies and workflows?","Question",{"text":63,"@type":64},"It comprehensively explores diverse technologies and methodologies for processing liquid biopsy biosources, followed by their main clinical applications.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},336693,1790167790,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,107,111,114,118],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":104,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":105,"slug":106},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},"Religion & Spirituality",20,"religion-spirituality",{"id":109,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":109,"slug":113},"World Cup","world-cup",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":115,"slug":117},10,"Lifestyle","lifestyle",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":89,"slug":121},19,"General","general",{"code":4,"msg":74,"data":123},{"doc_id":71,"user_id":124,"nickname":42,"user_avatar":125,"doc_module":4,"category_id":104,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":132,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":12,"update_tm":136,"read_time":137,"preview_page_count":33,"preview_urls":138},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","CELL ADHESION & MIGRATION 2024, VOL. 18, NO. 1, 1–26  \n[https://doi.org/10.1080/19336918.2024.2395807](https://doi.org/10.1080/19336918.2024.2395807)  \nREVIEW  \nLiquid biopsy: paving a new avenue for cancer research  \nKeerthi Kurma a,b,c*, Zahra Eslami-S a,b,c*, Catherine Alix-Panabières a,b,c, and Laure Cayrefourcq a,b,c*  \naLaboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France; bCREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France; cEuropean Liquid Biopsy Society (ELBS), Hamburg, Germany  \nABSTRACT  \nThe current constraints associated with cancer diagnosis and molecular profiling, which rely on invasive tissue biopsies or clinical imaging, have spurred the emergence of the liquid biopsy field. Liquid biopsy involves the extraction of circulating tumor cells (CTCs), circulating free or circulating tumor DNA (cfDNA or ctDNA), circulating cell-free RNA (cfRNA), extracellular vesicles (EVs), and tumor-educated platelets (TEPs) from bodily fluid samples. Subsequently, these components undergo molecular characterization to identify biomarkers that are critical for early cancer detection, prognosis, therapeutic assessment, and post-treatment monitoring. These innovative biosources exhibit characteristics analogous to those of the primary tumor from which they originate or interact. This review comprehensively explores the diverse technologies and methodologies employed for processing these biosources, along with their principal clinical applications.  \nARTICLE HISTORY  \nReceived 4 April 2024 Revised 21 May 2024 Accepted 14 August 2024  \nKEYWORDS  \nLiquid biopsy; biomarkers; circulating tumor cells;  \ncirculating free or tumor DNA; circulating cell-free RNA; extracellular vesicles; tumor-educated platelets  \nIntroduction  \nCancer is a pressing global health concern. It is among the most prevalent causes of death, and its prevalence is increasing worldwide [ 1] (World Health Organization. Cancer [https://www.who.int/news-room/fact-sheets/](https://www.who.int/news-room/fact-sheets/)[ ](https://www.who.int/news-room/fact-sheets/)[detail/cancer](detail/cancer. Accessed Nov 2021)[. Accessed Nov 2021](detail/cancer. Accessed Nov 2021)). The impact of cancer extends to the quality of life, imposing significant physical, emotional, and financial burdens on patients, their families, and the healthcare system. Despite extensive research aimed at elucidating the pathophysiology of cancer and the notable advancements in cancer management, the majority of metastatic cancers remain incurable, with 5-year survival rates falling below 25%[2](World Health Organization. Cancer. [https://www.who.int/news-room/](https://www.who.int/news-room/)[ ](https://www.who.int/news-room/)[fact-sheets/detail/cancer](fact-sheets/detail/cancer. Accessed Apr 2022)[. Accessed Apr 2022](fact-sheets/detail/cancer. Accessed Apr 2022)). Furthermore, cancer is often diagnosed at advanced stages when treatment tends to have limited efficacy. As cancer progresses, tumors tend to diversify, significantly influencing their response to therapy. Although treatment can eliminate dominant, susceptible cancer cells, a small subset of resilient cells may persist and continue to proliferate. Over the past decade, precision medicine has emerged as a ground breaking approach in oncology research. This approach revolves around sequencing each patient’s tumor and provides tailored insights [3]. The conventional benchmark for diagnosing tumors and conducting molecular profiling is tissue biopsy. However, this  \napproach is burdened with a range of challenges, including invasiveness and its associated issues such as bleeding, injury, infection, pain, limited access to tissue, and concerns related to sample adequacy, involving insufficient volume and suboptimal sample quality [4,5].  \nFurthermore, cancer diagnosis primarily relies on tissue biopsies, which only capture a partial representation ","cbCaico5PTVxIiVd","https://ap.wps.com/l/cbCaico5PTVxIiVd","pdf",1946053,26,"English","# Introduction\n## Liquid biopsy concept and rationale\n## Components and biomarkers\n## Clinical applications","[{\"question\":\"What does the review cover regarding technologies and workflows?\",\"answer\":\"It comprehensively explores diverse technologies and methodologies for processing liquid biopsy biosources, followed by their main clinical applications.\"}]","Liquid biopsy: paving a new avenue for cancer research | PDF",1790016210,66,[139,143,147,151],{"page_no":22,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fb4fac5d48500972ae62990ef7fa3b7.webp",983,1310,{"page_no":26,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf183118461be70d636d4273caa6f9b0.webp",982,1309,{"page_no":30,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aef4da410bccaebcc8faddb197d16713.webp",981,1308,{"page_no":33,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5bec4662445fb53e844c4c26ed5b2d2.webp",980,1306]